Clinical and Experimental Pediatrics

Search

Search

Close


Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-11.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 93

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 94

All issues > Volume 46(3); 2003

Case Report
J Korean Pediatr Soc. 2003;46(3):295-301. Published online March 15, 2003.
A Case of Glutaric Aciduria Type I with Macrocephaly
Woo Jong WJ Shin1, Yeo Ok YO Moon1, Hye Ran HR Yoon2, Eun Sil ES Dong3, Young Min YM Ahn3
1Department of Pediatrics, Kangnam General Hospital Public Co., , Korea
2Metabolic Disease Detection Laboratory, Seoul Medical Science Institute, Seoul, Korea
3Department of Pediatrics, Kangnam General Hospital Public Co., , Korea
Correspondence Young Min YM Ahn ,Email: ymahn@kangnamhosp.or.kr
Abstract
Glutaric aciduria type 1(GA1) is an autosomal recessive disorder of the lysine, hydroxylysine and tryptophan metabolism caused by the deficiency of mitochondrial glutaryl-CoA dehydrogenase. This disease is characterized by macrocephaly at birth or shortly after birth and various neurologic symptoms. Between the first weeks and the 4-5th year of life, intercurrent illness such as viral infections, gastroenteritis, or even routine immunizations can trigger acute encephalopathy, causing injury to caudate nucleus and putamen. But intellectual functions are well preserved until late in the disease course. We report a one-month-old male infant with macrocephaly and hypotonia. In brain MRI, there was frontotemporal atrophy(widening of sylvian cistern). In metabolic investigation, there were high glutarylcarnitine level in tandem mass spectrometry and high glutarate in urine organic acid analysis, GA1 was confirmed by absent glutaryl-CoA dehydrogenase activity in fibroblast culture. He was managed with lysine free milk and carnitine and riboflavin. He developed well without a metabolic crisis. If there is macrocephaly in an infant with neuroradiologic sign of frontotemporal atrophy, GA1 should have a high priority in the differential diagnosis. Because current therapy can prevent brain degeneration in more than 90% of affected infants who are treated prospectively, recognition of this disorder before the brain has been injured is essential for treatment.

Keywords :Glutaric aciduria type 1, Glutaryl-CoA dehydrogenase, Macrocephaly, Acute encephalopathy, Frontotemporal atrophy, Lysine free milk, Carnitine

Go to Top